GlaxoSmithKline Pharmaceuticals Ltd GLAXO-IN:National Stock Exchange of India

*Data is delayed | Exchange | INR
Last | 01/27/23 IST
1,263.00UNCH (UNCH)
52 week range
1,257.00 - 1,681.18
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1,263.00
  • 52 Week High1,681.18
  • 52 Week High Date01/24/22
  • 52 Week Low1,257.00
  • 52 Week Low Date01/27/23

Key Stats

  • Market Cap2,621.07M
  • Shares Out169.41M
  • 10 Day Average Volume61,138.73
  • Dividend30.00
  • Dividend Yield2.38%
  • Beta-
  • YTD % Change-3.48

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1,263.00
  • 52 Week High1,681.18
  • 52 Week High Date01/24/22
  • 52 Week Low1,257.00
  • 52 Week Low Date01/27/23
  • Market Cap2,621.07M
  • Shares Out169.41M
  • 10 Day Average Volume61,138.73
  • Dividend30.00
  • Dividend Yield2.38%
  • Beta-
  • YTD % Change-3.48

RATIOS/PROFITABILITY

  • EPS (TTM)23.22
  • P/E (TTM)54.39
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date07/07/2022
  • Div Amount60.00
  • Split Date-
  • Split Factor-

Latest On GlaxoSmithKline Pharmaceuticals Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the business of manufacturing, distributing, and trading in pharmaceuticals. It manufactures medicinal substances used in the manufacture of pharmaceuticals, such as antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts, and esters; glycosides and vegetable alkaloids, and chemically pure sugar. It offers a...
Renu Karnad
Non-Executive Chairman of the Board
Juby Chandy
Chief Financial Officer, Whole Time Director
S. Dheri
Executive Vice President - Vaccines
Address
Dr Annie Besant Road, Worli
Mumbai
400030
India